These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16629415)

  • 1. The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion.
    Barnett MH; Henderson AP; Prineas JW
    Mult Scler; 2006 Apr; 12(2):121-32. PubMed ID: 16629415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendrocytes and the early multiple sclerosis lesion.
    Prineas JW; Parratt JD
    Ann Neurol; 2012 Jul; 72(1):18-31. PubMed ID: 22829266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages in multiple sclerosis.
    Brück W; Sommermeier N; Bergmann M; Zettl U; Goebel HH; Kretzschmar HA; Lassmann H
    Immunobiology; 1996 Oct; 195(4-5):588-600. PubMed ID: 8933159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MS: is it one disease?
    Barnett MH; Parratt JD; Pollard JD; Prineas JW
    Int MS J; 2009 Jun; 16(2):57-65. PubMed ID: 19671369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathology in multiple sclerosis: new concepts.
    Lassmann H
    Mult Scler; 1998 Jun; 4(3):93-8. PubMed ID: 9762654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting myelin repair and return of function in multiple sclerosis.
    Zhang J; Kramer EG; Asp L; Dutta DJ; Navrazhina K; Pham T; Mariani JN; Argaw AT; Melendez-Vasquez CV; John GR
    FEBS Lett; 2011 Dec; 585(23):3813-20. PubMed ID: 21864535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
    Lucchinetti C; Brück W; Parisi J; Scheithauer B; Rodriguez M; Lassmann H
    Ann Neurol; 2000 Jun; 47(6):707-17. PubMed ID: 10852536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: lessons from neuropathology.
    Lucchinetti CF; Brueck W; Rodriguez M; Lassmann H
    Semin Neurol; 1998; 18(3):337-49. PubMed ID: 9817538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis.
    Lucchinetti CF; Brück W; Rodriguez M; Lassmann H
    Brain Pathol; 1996 Jul; 6(3):259-74. PubMed ID: 8864283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathology of MS: new insights and potential clinical applications.
    Pittock SJ; Lucchinetti CF
    Neurologist; 2007 Mar; 13(2):45-56. PubMed ID: 17351524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S
    Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
    Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
    Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring injury and repair of myelin and neurons in multiple sclerosis.
    Arnold DL; Chen J
    Ernst Schering Res Found Workshop; 2005; (53):173-86. PubMed ID: 16315614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage.
    Nessler S; Boretius S; Stadelmann C; Bittner A; Merkler D; Hartung HP; Michaelis T; Brück W; Frahm J; Sommer N; Hemmer B
    Brain; 2007 Aug; 130(Pt 8):2186-98. PubMed ID: 17617655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.